Vivian Li | Early Stage Investor
K2VC

Dr. Vivian Li holds a PhD in Biomedical Sciences from The Chinese University of Hong Kong and an MBA from Johns Hopkins University, with over a decade of experience spanning biomedical research, pharmaceutical R&D, venture investment, and biotech partnerships. She conducted postdoctoral research at the University of Pennsylvaniaand worked at GSK and ChemPartner, building expertise in drug discovery, translational medicine, and biomarker development. Today, Dr. Li is an early-stage investor at K2VC, where she evaluates and supports innovative biotech companies spanning novel therapeutics, emerging modalities, and platform technologies. Beyond direct investment, she works closely with biotech founders on company building, talent recruitment, fundraising, licensing, strategic partnerships, and global business development. Through her experience across research, pharmaceutical R&D, investment, and biotech ecosystems, Vivian has built a broad international network spanning academic institutions, startups, investors, pharmaceutical companies, and industry service providers. She bridges science and business, connects innovation with capital, and helps high-potential biotech companies advance from scientific discovery toward global impact.